ClinConnect ClinConnect Logo
Search / Trial NCT03996434

Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS

Launched by CLINAMYGATE · Jun 21, 2019

Trial Information

Current as of May 14, 2025

Completed

Keywords

ClinConnect Summary

Infertility affects up to one in seven couples all over the world. In vitro fertilization-embryo transfer (IVF-ET) and intracytoplasmic sperm injection (ICSI) are commonly used in the management of infertility attributable to tubal factor, significant endometriosis, male factor and also persistent unexplained infertility. Recruitment and development of multiple follicles in response to gonadotrophin stimulation are necessary for successful assisted reproduction. In young ovulating women undergoing IVF treatment, the standard stimulation protocol can result in either poor response or ovarian...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • infertile women
  • age 20-40
  • at high risk for OHSS
  • Exclusion Criteria:
  • refuse to participate

About Clinamygate

Clinamygate is a leading clinical trial sponsor dedicated to advancing medical research and innovation through the development and management of comprehensive clinical studies. With a focus on enhancing patient outcomes and accelerating the drug development process, Clinamygate collaborates with a diverse range of stakeholders, including pharmaceutical companies, research institutions, and healthcare providers. Our commitment to ethical practices and regulatory compliance ensures the highest standards of safety and efficacy in all trials. By leveraging cutting-edge technologies and a robust network of clinical sites, Clinamygate aims to bring transformative therapies to market efficiently and effectively, ultimately improving global health.

Locations

Cairo, , Egypt

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

Eman Elgendy, MD

Principal Investigator

International Islamic Centre for Population Studies and Research

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials